Free standard shipping on orders $300+ · Same-day dispatch before 2PM AEST
AUSTRALIAN OWNED & OPERATED
FAST DISCREET SHIPPING AUSTRALIA WIDE
LAB TESTED FOR PURITY & QUALITY
Customer Support:
contact@aussiepeptideco.com
Batch-verified · ≥99.0% purity (HPLC) Batch ZL-33-15 · Tested by Janoshik Analytical · 08/06/2026
View COA
Metabolic Research

Tirzepatide 15mg

Dual GIP / GLP-1 receptor agonist

Be the first to review SKU: APC-TIRZEPATIDE-15MG
Purity
≥99.0%
Lab Tested
Third-Party
Batch Specific
COA
$159.99 AUD
In Stock

Also available in 10mg · 30mg · 45mg · 60mg — compare all sizes

Quantity
Order within for same-day dispatch
Secure CheckoutSSL Encrypted
Fast Australia WideDiscreet Shipping
Orders before 2pm AESTDispatched Same Day

Also searched as: Tirz, GIP/GLP-1 dual agonist

Trusted Zynova Labs Supplier Genuine Zynova Labs research vials, stocked and dispatched from Melbourne.

Third-Party Tested

HPLC & mass spec verified purity

Batch Specific COA

Certificate with every batch

Discreet Packaging

Plain, unbranded, tamper-evident

Same-Day Dispatch

Before 2PM AEST, Australia-wide

Tirzepatide 15mg is a research compound supplied for laboratory investigation of metabolic and endocrine signalling pathways. Tirzepatide is a single synthetic peptide with activity at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The 15mg format provides researchers with a defined quantity for controlled experimental work. Tirzepatide research commonly focuses on incretin receptor signalling, glucose-related pathways, energy regulation and metabolic mechanisms.

What Is Tirzepatide 15mg?

Tirzepatide is a synthetic peptide engineered as a dual GIP and GLP-1 receptor agonist. These receptors are involved in several physiological signalling systems associated with glucose regulation, insulin secretion, appetite signalling and energy balance.

The compound is scientifically interesting because it enables researchers to investigate simultaneous activation of two incretin-related receptor pathways rather than studying GLP-1 receptor activity alone. Experimental and clinical research has examined how this dual-receptor mechanism influences metabolic signalling.

ManufacturerZynova Labs
Strength15mg
Molecular FormulaC225H348N48O68
Molecular Weight4813.5 g/mol
Purity≥99.0% (HPLC, batch ZL-33-15)
AppearanceWhite lyophilised powder
CAS No.2023788-19-2
FormLyophilised Powder
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryMetabolic Research
UsageFor Research Use Only. Not for human consumption.

Key Research Areas

Tirzepatide 15mg may be used in appropriately designed laboratory studies investigating:

Findings from experimental models should be interpreted according to the specific methodology and research setting.

Why Researchers Study Tirzepatide

A major research characteristic of tirzepatide is its dual-receptor pharmacology. GIP and GLP-1 belong to the incretin hormone system, but their receptors activate distinct and overlapping signalling processes.

Studying tirzepatide can therefore help researchers examine how coordinated GIPR and GLP-1R activation affects cellular and metabolic pathways. Its mechanism has also made it useful for comparing single-receptor and multi-receptor approaches in metabolic research.

Key Research Areas at a Glance

GIP and GLP-1 receptor signalling
Glucose-dependent metabolic pathways
Insulin-related signalling mechanisms
Energy homeostasis
Lipid and metabolic regulation
Incretin receptor interactions

Tirzepatide 15mg in Australia

Researchers searching for Tirzepatide 15mg Australia should verify current stock status, batch documentation, testing information and domestic shipping details before ordering. Product availability and Tirzepatide 15mg price should be confirmed on the current product listing.

This product is intended strictly for laboratory and in-vitro research purposes. It has not been evaluated for human or veterinary use, and any information provided here is for educational reference only.

Specifications

Product NameTirzepatide 15mg
ManufacturerZynova Labs
Strength15mg
Molecular FormulaC225H348N48O68
Molecular Weight4813.5 g/mol
Purity≥99.0% (HPLC, batch ZL-33-15)
AppearanceWhite lyophilised powder
CAS No.2023788-19-2
FormLyophilised Powder
VialSealed, sterile glass vial
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryMetabolic Research
TestingIndependent third-party HPLC & MS
DocumentationBatch-specific COA included
UsageFor Research Use Only. Not for human consumption.

Certificate of Analysis

Quality, Purity and Batch Testing

Tirzepatide 15mg should be evaluated using the analytical documentation supplied with the relevant batch. Researchers should review the Certificate of Analysis (CoA), stated purity, quantity and analytical testing information before experimental use.

Analytical purity should not be interpreted as evidence of clinical safety or therapeutic effectiveness.

CERTIFICATE OF ANALYSIS
Tirzepatide 15mg
Batch: ZL-33-15 · 08/06/2026
Janoshik Analytical Certificate of Analysis for Tirzepatide 15mg

Storage & Handling

Storage and Laboratory Handling

Store Tirzepatide 15mg according to the conditions stated on the product label and batch documentation. Where validated post-reconstitution stability information is unavailable, laboratories should follow their established research protocol rather than assuming a specific stability period.

Unopened VialStore at -20°C, protect from light & moisture
ReconstitutionBacteriostatic water (recommended)
After ReconstitutionRefrigerate at 2–8°C, use within 4 weeks
HandlingUse appropriate PPE and standard laboratory safety procedures
ShippingTracked, discreet delivery Australia-wide via Australia Post. Express available.

Reconstitution calculator: Tirzepatide 15mg

Work out concentration and the volume to draw for each aliquot before you add diluent.

mg
mL
Concentration
–
Volume per aliquot
–
On a 1 mL (U-100) syringe
–
Aliquots per vial
–

A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.

For Research Use Only. Not for human or veterinary consumption.

Tirzepatide 15mg: Frequently Asked Questions

It is a 15mg research format of the dual GIP/GLP-1 receptor agonist tirzepatide.

It activates both GIP and GLP-1 receptors.

It allows investigation of interacting incretin signalling pathways.

Research includes metabolic, glucose-related and endocrine signalling.

Yes. Tirzepatide is a single synthetic peptide rather than a peptide blend.

Refer to the relevant batch documentation or CoA library for current analytical information.

Follow the verified storage conditions supplied with the specific batch.

Check the current Australian product listing for stock, price and domestic shipping availability.

No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.

Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide 15mg”

Your email address will not be published. Required fields are marked *

Shopping Cart (0 items)

Your cart is empty

Add some research compounds to get started.

Browse Products